Interleukin-1β regulates cell proliferation and activity of extracellular matrix remodelling enzymes in cultured primary pig heart cells

Biochemical and Biophysical Research Communications

Volumn 399, Issue 4, 2010, Pages 542-547

  Zitta, Karina ^a   Brandt, Berenice ^a   Wuensch, Annegret ^b   Meybohm, Patrick ^a   Bein, Berthold ^a   Steinfath, Markus ^a   Scholz, Jens ^a   Albrecht, Martin ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cell proliferation; Extracellular matrix remodelling; Interleukin 1 ; Myocardial infarction

Indexed keywords

CASPASE 3; GELATINASE A; GELATINASE B; INTERLEUKIN 1 RECEPTOR; MATRIX METALLOPROTEINASE; PROCASPASE 3; RECOMBINANT INTERLEUKIN 1BETA; RNA; INTERLEUKIN 1BETA; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL LYSATE; CELL PROLIFERATION; COLORIMETRY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEART MUSCLE CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE; WESTERN BLOTTING; ZYMOGRAPHY; ANIMAL; APOPTOSIS; CELL CULTURE; ENZYMOLOGY; GENETICS; HEART; HEART INFARCTION; HEART MUSCLE; METABOLISM; PATHOLOGY; PHYSIOLOGY; REGENERATION;

ANIMALIA; SUIDAE;

ANIMALS; APOPTOSIS; CASPASE 3; CELL PROLIFERATION; CELLS, CULTURED; EXTRACELLULAR MATRIX; HEART; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MYOCARDIAL INFARCTION; MYOCARDIUM; RECEPTORS, INTERLEUKIN-1; RECOMBINANT PROTEINS; REGENERATION; SWINE;

EID: 77956262442     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.07.106     Document Type: Article

References (45)

1. Fox K.A., Birkhead J., Wilcox R., Knight C., Barth J.H. British Cardiac Society Working Group on the definition of myocardial infarction. Ann. Clin. Biochem. 2004, 41:263-271.
2. Wang O.J., Wang Y., Lichtman J.H., Bradley E.H., Normand S.L., Krumholz H.M. "America's Best Hospitals" in the treatment of acute myocardial infarction. Arch. Intern. Med. 2007, 167:1345-1351.
3. St John Sutton M., Lee D., Rouleau J.L., Goldman S., Plappert T., Braunwald E., Pfeffer M.A. Left ventricular remodeling and ventricular arrhythmias after myocardial infarction. Circulation 2003, 107:2577-2582.
4. Abbate A., Biondi-Zoccai G.G., Van Tassell B.W., Baldi A. Cellular preservation therapy in acute myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H563-H565.
5. Bersell K., Arab S., Haring B., Kuhn B. Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 2009, 138:257-270.
6. Bolshakova G.B. Cardiomyocyte proliferation in rat fetuses under normal conditions and after heart injury. Bull. Exp. Biol. Med. 2008, 145:487-489.
7. Tamamori-Adachi M., Takagi H., Hashimoto K., Goto K., Hidaka T., Koshimizu U., Yamada K., Goto I., Maejima Y., Isobe M., Nakayama K.I., Inomata N., Kitajima S. Cardiomyocyte proliferation and protection against post-myocardial infarction heart failure by cyclin D1 and Skp2 ubiquitin ligase. Cardiovasc. Res. 2008, 80:181-190.
8. Satoh M., Minami Y., Takahashi Y., Nakamura M. Immune modulation: role of the inflammatory cytokine cascade in the failing human heart. Curr. Heart Fail. Rep. 2008, 5:69-74.
9. Gullestad L., Aukrust P. The cytokine network in heart failure: pathogenetic importance and potential therapeutic targets. Heart Fail. Monit. 2001, 2:8-13.
10. Bergmann O., Bhardwaj R.D., Bernard S., Zdunek S., Barnabe-Heider F., Walsh S., Zupicich J., Alkass K., Buchholz B.A., Druid H., Jovinge S., Frisen J. Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98-102.
11. Nelson T.J., Martinez-Fernandez A., Yamada S., Perez-Terzic C., Ikeda Y., Terzic A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 2009, 120:408-416.
12. van Tuyn J., Pijnappels D.A., de Vries A.A., de Vries I., van der Velde-van Dijke I., Knaan-Shanzer S., van der Laarse A., Schalij M.J., Atsma D.E. Fibroblasts from human postmyocardial infarction scars acquire properties of cardiomyocytes after transduction with a recombinant myocardin gene. FASEB J. 2007, 21:3369-3379.
13. Porter K.E., Turner N.A. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol. Ther. 2009, 123:255-278.
14. Karpinski L., Plaksej R., Kosmala W., Witkowska M. Serum levels of interleukin-6, interleukin-10 and C-reactive protein in relation to left ventricular function in patients with myocardial infarction treated with primary angioplasty. Kardiol. Pol. 2008, 66:1279-1285.
15. Loppnow H., Westphal E., Buchhorn R., Wessel A., Werdan K. Interleukin-1 and related proteins in cardiovascular disease in adults and children. Shock 2001, 16(Suppl. 1):3-9.
16. Omerovic E., Bollano E., Soussi B., Waagstein F. Selective beta1-blockade attenuates post-infarct remodelling without improvement in myocardial energy metabolism and function in rats with heart failure. Eur. J. Heart Fail. 2003, 5:725-732.
17. Stumpf C., Seybold K., Petzi S., Wasmeier G., Raaz D., Yilmaz A., Anger T., Daniel W.G., Garlichs C.D. Interleukin-10 improves left ventricular function in rats with heart failure subsequent to myocardial infarction. Eur. J. Heart Fail. 2008, 10:733-739.
18. Zhang M.L., Mei J., Archer L.A., Obayashi M., Diao N., Stuyvers B., ter Keurs H.E. Effects of therapy using the Celacade system on structural and functional cardiac remodelling in rats following myocardial infarction. Can. J. Cardiol. 2009, 25:e241-e247.
19. Chung K.F. Cytokines as targets in chronic obstructive pulmonary disease. Curr. Drug Targets 2006, 7:675-681.
20. Timonen P., Magga J., Risteli J., Punnonen K., Vanninen E., Turpeinen A., Tuomainen P., Kuusisto J., Vuolteenaho O., Peuhkurinen K. Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy. Int. J. Cardiol. 2008, 124:293-300.
21. Meybohm P., Gruenewald M., Albrecht M., Zacharowski K.D., Lucius R., Zitta K., Koch A., Tran N., Scholz J., Bein B. Hypothermia and postconditioning after cardiopulmonary resuscitation reduce cardiac dysfunction by modulating inflammation, apoptosis and remodeling. PLoS One 2009, 4:e7588.
22. Zitta K., Meybohm P., Bein B., Rodde C., Steinfath M., Scholz J., Albrecht M. Hypoxia-induced cell damage is reduced by mild hypothermia and postconditioning with catalase in-vitro: application of an enzyme based oxygen deficiency system. Eur. J. Pharmacol. 2009, 628:11-18.
23. Liotta L.A., Stetler-Stevenson W.G. Metalloproteinases and cancer invasion. Semin. Cancer Biol. 1990, 1:99-106.
24. Whelan R.S., Kaplinskiy V., Kitsis R.N. Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu. Rev. Physiol. 2010, 72:19-44.
25. Frangogiannis N.G., Smith C.W., Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc. Res. 2002, 53:31-47.
26. Nian M., Lee P., Khaper N., Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ. Res. 2004, 94:1543-1553.
27. Bujak M., Dobaczewski M., Chatila K., Mendoza L.H., Li N., Reddy A., Frangogiannis N.G. Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am. J. Pathol. 2008, 173:57-67.
28. Deten A., Volz H.C., Briest W., Zimmer H.G. Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc. Res. 2002, 55:329-340.
29. Frangogiannis N.G. Chemokines in the ischemic myocardium: from inflammation to fibrosis. Inflamm. Res. 2004, 53:585-595.
30. Konrad L., Albrecht M., Renneberg H., Ulrix W., Hoeben E., Verhoeven G., Aumuller G. Mesenchymal entactin-1 (nidogen-1) is required for adhesion of peritubular cells of the rat testis in vitro. Eur. J. Cell Biol. 2000, 79:112-120.
31. Koebe H.G., Schildberg F.W. Isolation of porcine hepatocytes from slaughterhouse organs. Int. J. Artif. Organs 1996, 19:53-60.
32. Bujak M., Frangogiannis N.G. The role of IL-1 in the pathogenesis of heart disease. Arch. Immunol. Ther. Exp. (Warsz) 2009, 57:165-176.
33. Kaden J.J., Dempfle C.E., Grobholz R., Tran H.T., Kilic R., Sarikoc A., Brueckmann M., Vahl C., Hagl S., Haase K.K., Borggrefe M. Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis. Atherosclerosis 2003, 170:205-211.
34. Koudssi F., Lopez J.E., Villegas S., Long C.S. Cardiac fibroblasts arrest at the G1/S restriction point in response to interleukin (IL)-1beta. Evidence for IL-1beta-induced hypophosphorylation of the retinoblastoma protein. J. Biol. Chem. 1998, 273:25796-25803.
35. Palmer J.N., Hartogensis W.E., Patten M., Fortuin F.D., Long C.S. Interleukin-1 beta induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture. J. Clin. Invest. 1995, 95:2555-2564.
36. Boatright K.M., Salvesen G.S. Mechanisms of caspase activation. Curr. Opin. Cell Biol. 2003, 15:725-731.
37. Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell 2002, 9:459-470.
38. Spinale F.G. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol. Rev. 2007, 87:1285-1342.
39. Tyagi S.C., Campbell S.E., Reddy H.K., Tjahja E., Voelker D.J. Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts. Mol. Cell. Biochem. 1996, 155:13-21.
40. Siwik D.A., Chang D.L., Colucci W.S. Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ. Res. 2000, 86:1259-1265.
41. Xie Z., Singh M., Singh K. Differential regulation of matrix metalloproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1beta. J. Biol. Chem. 2004, 279:39513-39519.
42. Brown R.D., Jones G.M., Laird R.E., Hudson P., Long C.S. Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts. Biochem. Biophys. Res. Commun. 2007, 362:200-205.
43. Mukherjee R., Mingoia J.T., Bruce J.A., Austin J.S., Stroud R.E., Escobar G.P., McClister D.M., Allen C.M., Alfonso-Jaume M.A., Fini M.E., Lovett D.H., Spinale F.G. Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H2216-H2228.
44. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J. Pathol. 2003, 200:448-464.
45. Page-McCaw A., Ewald A.J., Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 2007, 8:221-233.